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Abstract
This chapter presents a review of the rehabilitation technologies for people who have suf-
fered a stroke, comparing and analyzing the impact that these technologies have on their 
recovery in the short and long term. The problematic is presented, and motor impair-
ments for upper and lower limbs are characterized. The goal of this chapter is to show 
novel trends and research for the assistance and treatment of motor impairment caused 
by strokes.
Keywords: stroke, hemiparesis, rehabilitation, assessment technologies, upper limb, 
lower limb, FES
1. Introduction
Stroke is the most common acquired neurological disease in the adult population worldwide 
(15 million every year [1]). Based on recently published studies, incidence of stroke in Europe 
at the beginning of the twenty-first century ranged from 95 to 290/100,000 per year [37]. Between 
2000 and 2010, the relative rate of stroke deaths dropped by 35.8% in the United States and 
other countries. However, each year stroke affects nearly 800,000 individuals, becoming the 
first cause of chronic disability and the third cause of death. It is a global public health prob-
lem worldwide that generates a significant burden of illness for healthy life years lost due to 
disability and premature death.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
One-third of stroke survivors achieve only a poor functional outcome 5 years after the onset 
of stroke. Although there is great progress in the management of acute stroke, most of the 
care to reduce dependence on post-stroke patients depends on rehabilitation. Optimal func-
tional recovery is the ultimate goal of neurorehabilitation after acute brain injury, mainly by 
optimizing sensorimotor performance in functional actions. New brain imaging techniques 
are making it clear that the neurological system is continually remodeling throughout life and 
after damage through experience and learning in response to activity and behavior.
Rehabilitation in stroke patients seeks to minimize the neurological deficit and its compli-
cations, encourage family, and facilitate social reintegration of the individual to ultimately 
improve their quality of life. Stroke rehabilitation is divided into three phases. The acute 
phase usually extends for the 1st weeks, where patients get treated and stabilized in a hospital 
and get stabilized. Subacute phase (1–6 months) is the phase where the rehabilitation process 
is more effective for recovering functions. In chronic phase (after 6 months), rehabilitation is 
meant to treat and decrease motor sequels.
The potential ability of the brain to readapt after injury is known as neuroplasticity, which is 
the basic mechanism underlying improvement in functional outcome after stroke. Therefore, 
one important goal of rehabilitation of stroke patients is the effective use of neuroplasticity 
for functional recovery [38].
As mentioned before, neural plasticity is the ability of nervous system to reorganize its struc-
ture, function, and connections in response to training. The type and extent of neural plastic-
ity is task—specific, highly time-sensitive and strongly influenced by environmental factors 
as well as motivation and attention.
Current understanding of mechanisms underlying neural plasticity changes after stroke 
stems from experimental models as well as clinical studies and provides the foundation 
for evidence-based neurorehabilitation. Evidence accumulated during the past 2 decades 
together with recent advances in the field of stroke recovery clearly shows that the effects of 
neurorehabilitation can be enhanced by behavioral manipulations in combination with adju-
vant therapies that stimulate the endogenous neural plasticity.
Nowadays, a large toolbox of training-oriented rehabilitation techniques has been developed, 
which allows the increase of independence and quality of life of the patients and their families 
[39]. The recovery of function has been shown to depend on the intensity of therapy, repeti-
tion of specified-skilled movements directed toward the motor deficits and rewarded with 
performance-dependent feedback.
The use of technological devices not only helps to increase these aspects but also facilitates 
the work of therapists in order to enhance the abilities of patients and a higher level of func-
tional recovery. They create environments with a greater amount of sensorimotor stimuli that 
enhance the neuroplasticity of patients, translating into a successful functional recovery. The 
use of technological devices can transfer the effects of rehabilitation to the different environ-
ments where patients spend their daily life allowing a favorable social reintegration. In this 
chapter, a review of technologies for rehabilitation of mobility in upper and lower extremity 
is presented.
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2. Motor impairments after stroke
One of the most important areas affected by stroke is motor skills. The patients may have disabili-
ties in different degrees (mid, acute, severe), in different hemispheres (one or both), and at differ-
ent levels: upper (face, neck), medium (trunk, upper limbs) and lower (lower limbs). Hemiparesis 
and motor recovery have been the most studied of all stroke impairments. Hemiparesis defined 
as muscular weakness or partial paralysis restricted to one side of the body is an impairment 
present in 88% of the stroke patients, affecting lower and upper limbs. Six months after stroke 
about 38% of patients lightly recovers dexterity in the arm and only 12% shows full recovery after 
conventional rehabilitation therapy [2]. Weakness and paresis are the most important impair-
ments on the early stages after stroke as they lead to a learned nonuse of limbs. Immobility, 
chronic pain, and some sensory impairments can also contribute to the learned nonuse state. As 
the recovery progresses, spasticity and spastic co-contractions can induce some compensatory 
movements, which if are persistent in time and repeated may contribute to a learned bad use [3].
For healthcare organizations, it is difficult to assess in a general and accurate way the effects 
that a stroke can have on people given the variety of areas involved. However, there are tools 
that assessing in a global way the degree of disability of the condition, regardless of the area 
where the impairment is found. In recent times, there are new technological tools to obtain 
data and also there are several tests that evaluate upper limb motor functions, trunk func-
tions, gait capacity, and spasticity. This allows health professional determine diagnosis and 
appropriate therapeutic interventions.
3. Upper limb problems
Many of the activities we do during the day involve using the upper limbs such as when eat-
ing, dressing, and writing. Their use is not only associated with the use of everyday instru-
ments but also with the contact with the world and the way we interact with other people. The 
accomplishment of these tasks requires sequences of complex movements that integrate the 
activation of appropriate muscular groups and the sensorimotor coordination of the hands, 
which translates into an effective functional action.
Grasp and manipulation are strategies of movement that are mainly affected in stroke patients. 
Recent studies have found that recovery is minimal in some individuals, particularly those 
with a flaccid paretic limb in the first few weeks. This is why dysfunction in upper limbs is a 
major clinical, economic, and social problem for neurorehabilitation teams. Hemiparesis on 
upper limb usually affects the hand causing weakness and spasticity, leading to a decrease in 
movement precision, muscle fatigue, lack of coordination, and an impaired ability to grasp 
objects, having a great impact on daily living activities [41].
Impairments such as a decreased motor impulse, a lower frequency of neuronal activation, poor 
sequencing and coordination of segmental movements, and sensory deficits have a marked 
influence on the functional performance of the upper limb. Muscle weakness and loss of manual 
dexterity may be accompanied by the development of soft tissue changes and shoulder pain.
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Many studies have shown that increasing therapy time in the upper limb from the acute 
stage reduces associated impairments and improves function satisfactorily from a clinical 
standpoint. This must be related to an intensity and dose of therapy appropriate to generate 
substantial changes.
It have been shown that patients have a better motor function when performing a specific 
task involving a useful interaction with an object, practice of strengthening exercises and 
functional actions is as important after stroke as for anyone attempting to gain strength and 
ability in motor actions [40].
3.1. Treatment-oriented devices and assistive devices for upper limb rehabilitation
In upper extremity rehabilitation, we can make a distinction between two categories of tech-
nologies. In the first category, we have treatment-oriented devices that are used to assist the 
exercises during the early rehabilitation process. The second category is made up of assistive 
devices, designed to aid patients in their daily living activities. Both categories may apply 
different therapeutic approaches, such as constraint-induced therapy, biofeedback therapy, 
and robot-aided therapy.
3.1.1. Treatment-oriented devices
This type of devices aims to help therapists in the flaccidity stage of hemiparesis due to the 
lack of neurologic connections. There is an agreement between therapists that early focused and 
repetitive exercise is the most important aspect for future recovery [4]. There is also evidence that 
early rehabilitation treatments may induce muscular reinnervation processes that can recover 
motor functions [5]. This category device can be subdivided into two more groups. The first 
consists mainly on mechanical structures to bring support to the limb and set constraints for the 
movements, like The Armeo® by Hocoma, and the Saebo ReJoyce (see Figure 1). They are used 
for exercising purposes promoting in this way the reinnervation of muscles in the affected limb.
Figure 1. Mechanical treatment devices. (a) Armeo Spring and (b) Saebo ReJoyce.
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Armeo Spring is an arm and hand rehabilitation exoskeleton with 5 degree-of-freedom (three in 
the shoulder, one in the elbow, one in the forearm) orthosis, which covers an individual's arm 
to protect, achieve a larger active range of motion and automatically guide his/her therapy 
by applying repetitive movements in an environment in which the subject is stimulated by 
interactive rehabilitation methods (videos, games, and instructions). The goal of this system is 
to restore the movement and functionality of the affected limb in less time than conventional 
therapeutic methods. This system is used in individuals who have suffered from strokes, trau-
matic brain injury, or other neurological disorders that induce hand and arm impairments [6].
Saebo Rejoyce is an upper limb training system used in people who have suffered upper limb 
impairments after strokes or other neurological conditions. It is a gaming system to practice 
gross and fine motor tasks, simulating functions like opening doors, opening jars, grasping 
and turning a cup, turning a key, and manipulating coins and other small objects, assessing 
and tracking his performance in order to generate a progress report by session [7].
In the second group, we find therapeutic stimulators like MyoTrac Saebo Infiniti and Neuromove 
900, which use functional electrical stimulation (FES) to exercise the grasping movements based 
on the acquisition of electromyography signals to trigger the stimulation pulse, in order to 
enable a more natural control using the user movement intent (see Figure 2) [8].
MyoTrack Infinity is a device used to reach the skeletal muscle re-education and the rehabilita-
tion of the arm, or other parts of the body, after strokes (or other affection), through the appli-
cation of electrical stimulation by the measure of a high-resolution surface electromyography.
Neuromove 900 is an electrical stimulator triggered by electromyography, sensing the muscu-
lar activity through reusable surface electrodes. The device evaluates the activity present in 
the muscle and then sets a higher standard that the patient should try to reach. Upon reaching 
the threshold, the patient is rewarded with electrical stimulation that makes the muscle move 
for a few seconds. Success is measured in the actual movement and gives the patient greater 
control over his/her extremity. It is used for stroke rehabilitation, spinal cord injury, manual, 
or stim only.
Figure 2. Treatment devices with FES capabilities. (a) Saebo MyoTrack Infinity and (b) Neuromove 900.
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3.1.2. Assistive devices
These types of systems are designed to aid sequel patients in their daily life activities, due to 
chronic conditions and lack of normal movement and functions. Besides the assistive goal of 
these devices, they also seek to promote a long-term recovery process. As expected these types 
of devices are designed to be portable and wearable. We could also subdivide this category 
into two: the one that uses stimulation and the mechanical only device. Some commercially 
available devices are the Bioness NESS H200 and the Saebo Glove. The Bioness NESS H200 is 
an FES device that consists of an orthosis that stabilizes the wrist of the affected limb to stimu-
late and contract the hand. Once positioned, this device allows grasp, hold, and release by 
neurostimulation. The Saebo Glove and Aider Stroke Rehabilitation Glove (see Figure 3) are 
glove-shaped devices that allow the extension of the hand by the action of elastic materials, 
generating support in patients who present a decreased grasping strength. These systems are 
used in patients that can only generate a limited closing grasping function and have almost 
fully compromised its ability to extend-back the fingers.
Bioness NESS H200 is an electronic device that consists in an orthosis and his control unit. The 
control unit transmits electrical pulses to the peripheral nerves through electrodes into the 
orthosis, activating five muscle groups of the forearm and the hand to generate the grasping 
moves of the hand. The advantage of this system is that it provides a proprioceptive input to 
the user, facilitating the normal control of the movements of the hand. Other benefits of the 
use of this device are reducing the muscle spasms, increasing or maintaining range of the 
movements, improving the blood circulation, and retarding the atrophy of the muscle.
SaeboGlove is an orthopedic glove that facilitates the movements of grasping of the hand support-
ing the extension of the fingers by elastics whose tension is adjusted according to the characteris-
tics of the individual. This system is fixed to the hand by means of two straps placed in the hand 
and in the forearm. It can also be combined with electrical stimulation techniques to support the 
hand closing movement. Individuals who had stroke, brain injury, brachial plexus injury, radial 
nerve palsy, individuals with limited wrist and finger extension are eligible to use this system.
Figure 3. Assistive devices for daily living support. (a) Bioness NESS H200 and (b) Saebo Glove.
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3.2. Upper limb assessment indexes and tests
During assessment of patients, there are different indexes that therapists use to evaluate the 
capabilities of the upper extremity functions. Reviewing literature and clinical trials, the most 
used are as follows:
The Fugl-Meyer assessment (FMA) is a stroke-specific, performance-based impairment index. 
It is designed to assess motor function, balance, sensation, and joint function in patients with 
post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, 
describe motor recovery, and to plan and assess treatment.
The action research arm test (MAS) is a performance-based scale to assess everyday motor func-
tion in patients with stroke. The MAS is based on a task-oriented approach, assessing perfor-
mance of functional tasks rather than isolated patterns of movement.
The Chedoke-McMaster stroke assessment measures physical impairment and disability in 
patients with stroke and other neurological impairment. The measure consists of an impair-
ment inventory and an activity inventory. The first inventory aims to determine the presence 
and severity of common physical impairments, to classify or stratify patients when planning, 
selecting interventions, and evaluating their effectiveness and to predict outcomes. The sec-
ond inventory measures changes in physical function. The Chedoke-McMaster stroke assess-
ment is a discriminative, predictive and evaluative tool.
The box and blocks test (BBT) is a functional test used in upper limb rehabilitation. The test is 
used to measure the gross manual dexterity of a patient or of a person using an upper limb 
prosthetic device.
3.3. Clinical evidence supporting technological devices in upper limb rehabilitation
Many studies regarding these types of systems have been reported in the literature, they all 
base their finding on randomized controlled trials, involving stroke patients to short-term 
therapies using this kind of devices and a control group subject to conventional therapy to 
determine whether rehabilitation protocols that use these technologies are improving the 
functional aspects and quality of life of stroke survivors with upper-limb deficits. In Table 1, 
we summarize some recent studies that compare hand function improvements between 
groups in rehabilitation with and without technological support.
As we can observe from the results above, the groups that were treated with this type of 
devices showed greater improvements in some of the evaluated aspects than the ones that 
received traditional manual therapy. Devices that offered mechanical support and mechani-
cal movement assistance did report an increase in strength and hand reaching. This improve-
ment can be explained by muscle recovery from atrophy state due to cyclical exercising and 
also to the reduced force needed to maintain the arm position from the gravity compensation, 
effort that can be focused on extension muscles. Other important factor to notice is the usage 
of FES to aid the movements in some devices. Almost every device with FES capabilities 
reported an improvement compared to the control groups in hand opening and reaching. 
An important factor to notice here is that the benefits from FES were maintained after the 
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 interventions (follow-up tests) only when the stimulation was triggered by the user itself, 
such as EMG-triggered or contralaterally controlled therapy. The main idea that resides here 
is the treatments that involve cognitive awareness from the user generate favorable condi-
tions in rehabilitation and promote faster motor control recovery. Motivation is a key factor 
that determines the achievements during rehabilitation therapies; in this way, devices that 
maximize cognitive engagement during the process are the ones that report the most improve-
ments in contrast with traditional therapy. EMG-triggered devices with FES capabilities are 
the most promising regarding clinical results. Even though many of the clinical reports with 
use of technological assistive devices are relatively short-term evaluations, trends in rehabili-
tation achievements are positive in almost every aspect of the assessment indexes used. Long-
term evaluation and clinical reports are underway as stated in many of the cited publications, 
considering also a most representative number of patients to obtain statistical data that would 
allow to validate the favorable trends observed in these studies.
4. Lower limb problems
The ability to walk independently is a prerequisite for most activities of daily living. The ability 
to walk in a community environment requires the ability to walk at speeds that allow the indi-
vidual to cross the street in the time set by traffic lights, under or over objects or handling curbs.
Reference Hemiparetic 
side
Post-stroke 
time
N of 
patients
Intervention 
time
Device type Assistance 
type
Improvements
Krabben et al. [9] Single side 12 months 
(AVG)
8 – Assistive  
w/FES
GC* and 
FES
Hand 
opening
Kim et al. [10] Single side <6 months 30 5 weeks Treatment  
w/FES
EMG-
triggered 
NMES
RT** of 
hemiparetic 
wrist
Knutson et al. [11] Single side <6 months 6 6 weeks Treatment  
w/FES
CCFES*** Dexterity, 
MAFEA****, 
reaching, 
hand 
opening
Knutson et al. [11] Single side >6 months 21 12 weeks Treatment  
w/FES
CCFES*** MAFEA****
Fischer et al. [12] Single side <6 months 15 5 weeks Treatment Cyclic 
stretching
Strength 
gain,
Makowski et al. [13] Single side >6 months 3 – Treatment  
w/FES
Arm 
support  
and FES
Hand 
opening and 
reaching
* GC, gravity compensation.
** RT, reaction time.
*** CCFES, contralaterally controlled functional electrical stimulation.
**** MAFEA, maximum active finger extension angle.
Table 1. Clinical reports for upper extremity improvements compared with traditional therapy.
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Gait dysfunction is common in individuals with neurological disorders not only due to injury-
related disorders but also to the cardiovascular and musculoskeletal consequences of disuse 
and physical inactivity. Impairments following stroke usually involve an excessive energy 
cost during walking, which limits the type and duration of activities. Stroke patients are gen-
erally unable to comfortably maintain the most efficient walking speed beyond a very short 
distance [42]. These individuals are often restricted only to activities of daily living within 
confined spaces in the home and with little possibility of performing functional activities at 
community level, which restricts their social participation and ultimately affects their quality 
of life and independence. Some of the limitations that can be observed in patients with stroke 
are related to poor motor control, muscle weakness and/or soft tissue shortening, sensory 
and balance disturbances, among others. These impediments are specifically translated into 
pathological characteristics of gait that affect the proper sequential activation of the muscles 
in the different stages of gait, causing compensatory strategies that decrease gait speed and 
efficacy and that may increase the risk of falls from the patients.
One of the most common impairments observed in walking of stroke patients is the reduc-
tion of ankle dorsiflexion during hill contact and during the support phase associated with 
a hyperextension of the knee, which results in a fall of the foot during gait. This may be due 
to decreased activation of the anterior tibial muscle, as well as to premature activation of the 
calf muscles. This condition not only affects the gait speed but also limits the ability to walk 
in irregular ground and surfaces and go up and down stairs. This impairment is commonly 
known as drop foot. Drop foot is a disorder characterized by a lack of voluntary control of 
dorsiflexor muscles. A person with foot drop cannot lift the front of the foot before the heel 
comes in contact with the ground, which can cause tripping or falling. As a result, patients 
develop compensatory strategies including pelvic obliquity, hip hiking, and hip abduction 
with circumduction gait pattern to preserve foot clearance, see Figure 4. These strategies 
increase significantly the energy consumption of the person. With the objective of improving 
gait efficiency and safety, and overall improvement of the gait pattern to reduce musculoskel-
etal stress from altered biomechanics, many treatment modalities have been used. Treatment 
modalities include stretching, exercise, rehabilitation, orthotics, and assistive devices.
Figure 4. Walking pattern in person with drop foot [14].
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4.1. Assistive technologies devices for lower limb rehabilitation
4.1.1. Ankle foot orthosis (AFO)
Regarding assistive-type technologies, the common method for the treatment of the droop is 
ankle-foot orthoses (AFO). In general, AFOs stabilize the foot and ankle by lifting the tip of 
the toes when the foot loses contact with the surface while walking, providing stability, con-
trol, and protection for the foot. Moreover, this assistive tool grants proprioceptive feedback 
to know the position that the foot has in space.
There are a large number of AFOs, which differ from one other according to the medical and 
biomechanical needs of the individual. Some types of AFOs are flexible ankle-foot orthoses, 
hinged ankle-foot orthoses, tubular ankle-foot orthoses, silicone ankle-foot orthoses (SAFO), 
Charcot restraint orthotic walker, and plantar fasciitis night-splint (see Figure 5).
Flexible ankle-foot orthoses are lightweight orthoses whose design prevents the foot from per-
forming plantar flexion, preventing its fall, allowing a smooth sway of the foot without the 
finger dragging on the floor. In general, the shape of these orthoses depends on the needs of 
the user. Flexible AFOs are made with propylene plastic, with a Velcro that allows closing and 
fixing the orthosis to the leg. They are used for people who have suffered a stroke, multiple 
sclerosis, poliomyelitis, or other nerve damage.
Hinged AFOs are effective elements that are used for the control of plantar flexion, dorsi flex-
ion, and lateral movements. Many designs are used with a wide variety of hinges, which are 
selected based on the requirements of the user and considerations regarding the weight and 
shape of the device. Hinged AFOs are used for people who suffer from droop foot such as 
strokes (CVA) or cerebral palsy. They are generally made of plastic.
Figure 5. Ankle-foot orthoses described. (a) Flexible ankle-foot orthoses, (b) hinged ankle-foot orthoses, and (c) silicone 
ankle-foot orthoses.
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Tubular AFOs also called circumferential AFOs enclose the leg and foot completely. The 
detachable strap provides great stability and protection for the leg and foot. The clamp is lined 
with foam and antimycotic leather to add protection for sensitive skins. Tubular AFO is most 
commonly used for people with diabetic complications or other peripheral neuropathies.
SAFO is a more current design, used for people who have flaccid foot paralysis as a sequel to 
pathologies such as Charcot-Marie-tooth disease, multiple sclerosis, poliomyelitis, stroke, and 
spinal cord injury. Its design offers an optimal proprioception so that the user can know and 
feel in a more comfortable way the position of his foot in space, giving a great control to the 
plantar flexion. The orthosis has a very low profile, adapting to the shape of the individual's 
foot, allowing it to be worn with or without shoes.
These types of elements have proven to be very useful, significantly improving the dynamics 
with which the gait exercise is performed [15–17]. Studies show that regardless of the material 
and the type of AFO used, the measurable parameters for gait exercise (cadence, joint angles, 
balance) do not differ from each other, the most important being the comfort and security that 
these elements confer to the individual at the time of choosing them.
Lately, control systems have been developed for AFOs in order to dampen the force with 
the foot reaches the ground in the support stage of the gait and generates a certain level of 
dynamics in the movement of the foot adjusting the rigidity between the foot and ankle. 
These systems are called active ankle-foot orthoses (AAFO) (see Figure 6). The control sys-
tem, developed by Joaquin A. Blaya and Hugh Herr, works by applying a dynamically 
controlled torque to the orthosis joint, to cushion the shock of the foot on the floor while 
Figure 6. Active ankle-foot orthoses (AAFO) developed by Joaquin A. Blaya and Hugh Herr [18].
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the foot is falling. Then, after the placement of the foot, the control system minimizes the 
stiffness of the orthosis to allow plantar flexion of the subject until the foot loses contact 
with the ground entering the swing phase of the gait, where a constant stiffness is applied 
to force the dorsiflexion of the foot. Tests show that the active stiffness adjustment reduces 
the occurrence of slap foot, allows greater powered plantar flexion, and provides for less 
kinematic difference during swing compared to normal, presenting a system that has clini-
cal benefits compared to the conventional orthoses [18].
However, AFOs have a number of disadvantages and limitations, since these devices do not 
promote active movement, can be uncomfortable, bulky and, if misplaced, produce areas of 
pressure pain and tissue breakdown. This is why functional electrical stimulation (FES) is 
used as an alternative to AFOs.
4.1.2. Functional electrical stimulation (FES)
Functional electrical stimulation is a rehabilitation technology that uses electrical periodic 
pulses to stimulate the nerves that produce contractions in paralyzed muscles and recover 
lost functions. There are two ways to apply FES: surface FES and implanted FES.
4.1.2.1. Surface FES
Liberson in 1961 [19] proposed the use of FES to correct drop foot. He created a system that 
uses electrical stimulation applied to the common peroneal nerve, recruiting muscles involved 
in dorsiflexion and eversion of the ankle. The operation of the system is as follows: two super-
ficial electrodes are located just below the head of the fibula bone. Using a foot switch placed 
in the shoe under the heel, the stimulation pulses are synchronized with the gait cycle. Then, 
the foot is lifted through the swing phase. The typical stimulation profile (see Figure 7) is 
often a ramping up and down of the stimulus. The rise and fall of the stimulation envelope 
can be adjusted to prevent a stretch reflex in the calf muscles and to prevent foot flap due to 
the premature ending of dorsiflexion.
Figure 7. Typical stimulation pulse profile on drop foot FES in each stage of the gait cycle.
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The use of these devices can be classified in two ways [20]: the first is the orthotic effect that 
is the direct effect of using the FES (lift the toe). The second effect is the therapeutic effect 
and relates to changes in walking ability when not using FES. Although not widely used or 
universally available, there is growing evidence that treatment with FES improvements in 
gait speed, cadence, improved confidence in walking, reduction in the risk of falling, less 
effort during walking, and the active contraction produced by FES can help to prevent muscle 
atrophy.
Since, many research groups have designed and studied new stimulators that are based on the 
work of Liberson, creating FES devices currently commercially available, such as the Odstock 
dropped foot stimulator (ODFS®, Odstock Medical Limited, Salisbury, UK), the WalkAide® 
system (Innovative Neurotronics Inc., Austin, TX, US), the Bioness NESS L300® foot drop 
system (Bioness Inc., Valencia, CA, US), and the MyGait® system (Ottobock, Duderstadt, 
Germany).
Odstock dropped foot stimulator: The ODFS is single channel; it is controlled with a wired 
foot switch placed in the shoe, which is used to turn on and off the stimulation at the right 
time while walking (see Figure 8a). In 2016, a wireless version of the footswitch began to 
be commercialized. Typically, skin surface electrodes are placed over the common pero-
neal nerve as it passes over the head of the fibula bone and the motor point of the tibialis 
anterior.
Walkaide system: The Walkaide is also cuff-based surface stimulator (see Figure 8b). The main 
difference from other systems is that it uses an inertial gait sensor to trigger the stimulation 
based on acceleration thresholds. However, it has the option of a wired foot switch. Internally, 
it has an algorithm that auto-adjusts the parameters for each patient.
Figure 8. Surface FES systems available commercially: (a) ODFS system [21], (b) Walkaide System [22], (c) My Gait 
System [23], (d) Ness L300 [24], (e) SmartFES System [43].
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Ness L300 system: The Ness L300 is a surface FES system that includes the stimulation unit based 
in a cuff, a wireless foot switch, and hand-held control for intensity control (see Figure 8c). 
Recently, the L300 plus was released. This consists of a thigh cuff to give you greater control 
over bending and straightening your knee, which may help you walk more naturally.
My Gait: Is the newest surface stimulator launched in 2013. It is a cuff-based surface stimula-
tor (see Figure 8d). The novelty of this stimulator is that it provides two channels. The sec-
ond channel is integrated and does not need an additional device. By stimulating additional 
muscle groups, gait performance can be further improved. It can be employed to support 
in flexion or extension of the knee, improved triggering of the swing phase, and minimized 
compensatory movements.
SmartFES: Surface stimulator launched in 2016. The SmartFES Is a low cost single channel 
stimulator, it is controlled with a wired foot switch placed in the shoe. The main difference 
from other systems is the Unit Interface (UI). The UI is implemented in an Android applica-
tion and allows to modify the stimulation parameters in order to obtain the best response of 
dorsiflexion. The unit interface communicates via Bluetooth with the stimulator. This allows 
an easy and fast operation. Actually the SmartFES is being commercialized in Chile.
Table 2 summarizes the technical characteristics of the systems mentioned above.
Many research studies have demonstrated that FES combined with conventional physio leads to 
further improved results, compared to conventional therapy alone [25]. Taylor et al. test the ODFS 
stimulator in 32 subjects [26]. The results show that 71% of ODFS users were able to walk further. 
Additionally, it was reported that 33% of users used the device to keep them fit, 70% used the 
Ness L300® Walkaide® ODFS Pace® MyGait®
Manufacturer Bioness 
Neuromodulation  
Ltd.
Innovative 
Neurotronics  
Inc.
Odstock  
Medical Ltd
Ottobock  
Healthcare  
Products GmbH
Neurotech  
Spa. SmartFES
Amplitude (mA) 0–80 @ 1 k 0–121 @ 1 k 10–100 @ 1k 0–90 @ 1k 10–100 @ 1kΩ
Number of channels 1 1 1 2 1
Frequency (Hz) 20–45 16.7–33 0–60 10–80 10–60
Pulse width (us) 100/200/300 25–300 0–360 50–400 10–300
Foot switch Wireless Inertial/wired Wired/wireless Wireless Wired Foot  
Switch
Waveform Biphasic  
symmetrical/
asymmetrical
Biphasic 
asymmetrical
Biphasic  
symmetrical/
asymmetrical
Biphasic 
symmetrical/
asymmetrical
Biphasic 
Asymmetrical
Regulated current  
or regulated voltage
Regulated  
current
Constant voltage Regulated 
current
Regulated  
current
Regulated  
Current
Battery 1 built in 1 replaceable 1 replaceable 1 built in 1 built in
Rechargeable Yes No No Yes Yes
Country USA Canada UK Germany Chile
Table 2. Commercial surface FES stimulator to correct drop foot.
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ODFS for shopping and trips out, 57% used for social events, 19% for work; 79% users reported 
that their confidence was increased when walking and 52% reported that their independence was 
increased. Van Swigchem et al. [27] reported similar increases in gait velocity and cadence of 26 
stroke patients with the Ness L300. Stein et al. [28] did an analysis with the Walkaide system of the 
orthotic and therapeutical effect among patients with a nonprogressive (stroke) and progressive 
(multiples sclerosis) disease. The mean walking speed at all times was typically 5–15% higher with 
the device than without the device for both the progressive and nonprogressive groups. Therefore, 
the immediate improvement is referred to as an orthotic effect. With respect to long-term changes 
as therapeutic effects, after 11 months the therapeutic effect was much larger for the nonprogres-
sive group (about 30%) than for the progressive group (about 5%). It is necessary to make clear 
that the use of FES is not appropriate for all stroke patients. The patient has to be well motivated, 
able to walk with assistance or alone, and the muscle that raises the foot must not be denervated.
Despite the benefits of these devices, the surface FES devices have some disadvantages. When 
using surface electrodes, the lack of selectivity of muscles and nerves affected by superficial 
electrodes is a problem. The stimulation could be felt as “pins and needles” that in some cases 
can cause pain or discomfort. The other problem reported is skin irritation [29], and these 
cases are usually treated by changing the type of electrodes or modifying the stimulation set-
tings. These problems can be solved by using implanted stimulators.
4.1.2.2. Implanted FES
Implanted devices eliminate the need to position electrodes on the skin each day and reduce 
all problems associated with surface stimulation. No soft tissue or skin reactions, no need for 
technically challenging electrode placement and no discomfort or pain due to constant electri-
cal sensation through the skin.
These stimulators work by activating directly the nerve that controls the lifting of the foot, 
called common peroneal nerve. At a point, just below the knee, this nerve splits into two 
branches: the deep branch and the superficial branch. The deep branch goes to the muscles 
that lift (dorsiflex) and turn inward (inversion) the foot, while the superficial branch innerves 
the muscles that turn the foot outwards (eversion). In normal walking, a combination of these 
movements is required. Like a surface stimulator, the implanted stimulator uses a foot switch 
to detect the step and an external FES device activates the implant through a wireless antenna 
worn on the outside of the body.
Currently, there are two implantable devices to correct drop foot available in the market: 
the STIMuSTEP system (Finetech Medical Ltd., Welwyn Garden City, UK) and the ActiGait 
system developed by Neurodan A/S (Aalborg, Denmark), a subsidiary of Ottobock group 
(Berlin, Germany).
STIMuSTEP system: This system is a passive implantable dual channel peroneal nerve stimu-
lator triggered by a foot switch (see Figure 9a). Communication between the external control 
unit and the foot switch is wired. Electrodes are surgically inserted, one in the deep branch 
and other in the superficial branch enabling the movements (dorsiflexion, eversion end inver-
sion) to be controlled separately.
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ActiGait system is an implantable four-channel nerve stimulator with a 12-contact electrode cuff 
(see Figure 9b). It works with a foot switch, which is worn in a sock, which triggers the initiation 
and termination of each stimulation sequence by a radio frequency wireless signal to the external 
control unit. The nerve stimulator contains a receiver for power and control and transmits the 
stimulation to the 12-electrode cuff through a subcutaneous cable [30]. The four channels can be 
programmed to allow for selective nerve bundle stimulation and balanced dorsiflexion/eversion.
Table 3 summarizes the technical characteristics of the systems mentioned above.
In general, surface and implanted FES reported similar results. The prescription of an implant-
able peroneal nerve stimulator is only a treatment option when the main goal is to achieve 
an orthotic effect for the long term in drop foot patients [32]. Burridge et al. [33] reported 
significant increases in mean gait distance and velocity (19%) using the ActiGait system. In a 
research conducted by Taylor et al. [26] 46 drop foot patients were selected from ODFS system 
users that had skin irritation, difficulties with electrode placement or anticipated long-term 
use with the device. Increases of 18% in gait velocities were reported. Additionally, patients 
also reported a more comfortable gait. In general, these devices are safe; however, an implant 
always has the risk of infection/rejection.
Figure 9. Implanted FES systems available commercially: (a) STIMuSTEP System [31] and (b) ActiGait System [32].
ActiGait STIMuSTEP
Manufacturer Developed by Neurodan A/S a subsidiary 
of Ottobock Medical Ltd.
Finetech Medical Ltd.
Amplitude (mA) 1.2 16
Number of channels 4 2
Frequency (Hz) 5–50 30
Pulse width (us) 0–300 300
Sensor Wireless foot switch Wired foot switch
Waveform Biphasic symmetrical Biphasic asymmetrical
Regulated current or regulated voltage Regulated current Constant voltage
Country Denmark/Germany UK
Table 3. Commercial implanted FES stimulator to correct drop foot.
Physical Disabilities - Therapeutic Implications110
4.2. Robotic devices
Another technology that improves gait rehabilitation is robotic devices. These devices are 
characterized by providing safe, intensive and task-oriented rehabilitation. Lokomat Hokoma 
and the G-EO system (Reha-Technologies, Germany, GT) are some examples of low-limb 
robotic rehabilitation devices, which base their operation on restoring movement through 
repetitions in an assisted way, improving muscle strength, coordination, and locomotor 
retraining, reducing the rehabilitation, and/or recovery times of patients with stroke com-
pared to methods based only on conventional kinesiological treatment techniques [34].
Lokomat is an exoskeleton consisting of a treadmill, a harness that allows different degrees of sup-
port of body weight and articulated arms that are placed embracing both legs (see Figure 10). 
These electromechanical arms mobilize hips and knees to perform the proper walking move-
ments on the treadmill, in which the patient actively intervenes according to his possibilities 
[35]. It offers a physiological gait pattern with constant feedback and therapy assessment. 
It improves patient outcomes by increasing therapy volume and intensity, providing task-
specific training, and increasing patient engagement.
G-EO SYSTEM is a device that consists of a harness, pedals for the user’s feet, a central acquisi-
tion and control, where you can select the threshold levels for rehabilitation and incorporate 
two modes (see Figure 11). This is one of the most modern systems and has the capacity to 
simulate a walking on a level and on a ladder. It has two modes of operation. The first one, 
active mode, helps the patient to self-initiate the gait activity when a pre-selected mechanical 
Figure 10. Lokomat®Nanos, using the same principles as LokomatPro Hocoma, but more compact.
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resistance “threshold” was adjusted. The second one, active-assistive mode, senses the patient’s 
efforts to overcome the preselected-resistance threshold and then augments the patient's effort 
during the initiation of their gait movement [36].
Both systems previously described allow patients to regain their ability to walk in less time when 
compared to conventional therapy approaches, but it is strongly linked to the follow-up and type 
of therapy to which they are subject, since there is also evidence that indicates poor results [34].
5. Conclusions
The stroke (ACV) is a condition that in most cases leaves people who suffered it in an invalidat-
ing condition, ranging from cognitive problems to physical problems. From the point of view 
of physical affections, a great number of technologies and devices have been implemented 
that support not only the recovery and treatment of people but also their daily chores. In this 
chapter, a large number of assistive and rehabilitation systems have been presented, from the 
simplest ones like gloves, that serve to assist the opening of the hand, to more advanced sys-
tems like exoskeletons that are focused on facilitating complex movements in large degrees of 
freedom through interactive rehabilitation techniques.
With respect to the assistive systems, there are focused on recovering a certainly lost function 
of the user, allowing the increase of its independence. At present, a large number of systems 
based on functional electrical stimulation have been developed, applying electrical pulses 
to the muscles and/or nerves that are involved in the control of the intended movement. 
Recent applications seek to make these systems more portable, even moving to implantable 
solutions.
For the rehabilitation devices, it can be seen that the developing systems focused on rehabili-
tation are aimed at the creation and implementation of automated care methods that allow 
keeping the user motivated and thus improve their time of rehabilitation and/or recovery.
Figure 11. The G-EO system for gait rehabilitation.
Physical Disabilities - Therapeutic Implications112
However these systems are promising, their performance will be strongly linked to the pro-
gram that the professional in charge applies with them.
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